feed,title,long_url,short_url
Benzinga,Why Torm Shares Are Getting Hammered,https://benzinga.com/news/23/03/31586800/why-torm-shares-are-getting-hammered,https://da.gd/KY8u
Benzinga,Bolt Biotherapeutics Says Phase 1 Data Supports Advancing Into Phase 2 Studies,https://benzinga.com/general/biotech/23/03/31584214/bolt-biotherapeutics-says-phase-1-data-supports-advancing-into-phase-2-studies,https://da.gd/Trx7bh
